Sensei Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNSE and other ETFs, options, and stocks.

About SNSE

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD. 

CEO
Christopher W. Gerry
CEOChristopher W. Gerry
Employees
29
Employees29
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
1999
Founded1999
Employees
29
Employees29

SNSE Key Statistics

Market cap
34.68M
Market cap34.68M
Price-Earnings ratio
-1.35
Price-Earnings ratio-1.35
Dividend yield
Dividend yield
Average volume
32.23K
Average volume32.23K
High today
$27.70
High today$27.70
Low today
$25.78
Low today$25.78
Open price
$27.70
Open price$27.70
Volume
23.71K
Volume23.71K
52 Week high
$36.76
52 Week high$36.76
52 Week low
$5.25
52 Week low$5.25

Stock Snapshot

The current Sensei Biotherapeutics(SNSE) stock price is $25.86, with a market capitalization of 34.68M. The stock trades at a price-to-earnings (P/E) ratio of -1.35.

As of 2026-05-06, Sensei Biotherapeutics(SNSE) stock has fluctuated between $25.78 and $27.70. The current price stands at $25.86, placing the stock +0.3% above today's low and -6.6% off the high.

Sensei Biotherapeutics(SNSE) shares are trading with a volume of 23.71K, against a daily average of 32.23K.

During the past year, Sensei Biotherapeutics(SNSE) stock moved between $5.25 at its lowest and $36.76 at its peak.

During the past year, Sensei Biotherapeutics(SNSE) stock moved between $5.25 at its lowest and $36.76 at its peak.

SNSE News

TipRanks 21h
Sensei Biotherapeutics announces first patient dosed in FTH-PIK-101 trial

Sensei Biotherapeutics (SNSE) announced that the first patient was dosed in Study FTH-PIK-101, a Phase 1b/2 trial of PIKTOR in patients with HR+/HER2- advanced...

People also own

Based on the portfolios of people who own SNSE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.